E-LIB Suche - Ergebnisse für: de LaIglesia, Almudena

1

Clinical outcomes after CPX‐351 in patients with high‐risk ..:

Bernal, Teresa ; Moreno, Ainhoa Fernández ; de LaIglesia, Almudena...
Cancer Medicine. 12 (2023) 14 - p. 14892-14901 , 2023

Link: https://doi.org/10.1002/..

2

Treatment of Myeloid Neoplasms with HLA-Mismatched Stem Mic..:

Trillo, Rosalia Alonso ; de Laiglesia, Almudena ; Martínez-Muñoz, María Esther...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S427-S428 , 2023

Link: https://doi.org/10.1016/..

3

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLA..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
HemaSphere. 7 (2023) S3 - p. e835897e , 2023

Link: https://doi.org/10.1097/..

4

Incidence, risk factors, and outcomes of second neoplasms i..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
Annals of Hematology. 103 (2023) 2 - p. 451-461 , 2023

Link: https://doi.org/10.1007/..

5

Use of Venetoclax in Patients with Relapsed or Refractory A..:

Labrador, Jorge ; Saiz-Rodríguez, Miriam ; de Miguel, Dunia...
Cancers. 14 (2022) 7 - p. 1734 , 2022

Link: https://doi.org/10.3390/..

6

Single Cord Blood Unit Plus Third Party Donor Cells (Haplo-..:

Bautista, Guiomar ; Canals, Carmen ; Kwon, Mi...
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S192-S193 , 2018

Link: https://doi.org/10.1016/..

7

Busulfan‐based myeloablative conditioning regimens for hapl..:

Gayoso, Jorge ; Balsalobre, Pascual ; Kwon, Mi...
European Journal of Haematology. 101 (2018) 3 - p. 332-339 , 2018

Link: https://doi.org/10.1111/..

8

HLA-partially matched cellular therapy (stem-cell microtran..:

Forés, Rafael ; Dorado, Nieves ; Vilches, Carlos...
British Journal of Haematology. 165 (2014) 4 - p. 580-581 , 2014

Link: https://doi.org/10.1111/..

9

Rhodotorula species fungaemia causes low mortality in haema..:

Forés, Rafael ; Ramos, Antonio ; Orden, Beatriz...
Mycoses. 55 (2012) 3 - p. , 2012

Link: https://doi.org/10.1111/..

10

Haematopoietic transplants combining a single unrelated cor..:

Sebrango, Ana ; Vicuña, Isabel ; de Laiglesia, Almudena...
Best Practice & Research Clinical Haematology. 23 (2010) 2 - p. 259-274 , 2010

Link: https://doi.org/10.1016/..

11

P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN F..:

Tormo, Mar ; Diaz-Beya, Marina ; Beneit, Paola...
HemaSphere. 7 (2023) S3 - p. e4025574 , 2023

Link: https://doi.org/10.1097/..

12

Clinical outcomes after CPX-351 in patients with high-risk ..:

Bernal del Castillo, María Teresa ; Fernandez Moreno, Ainhoa ; LaIglesia, Almudena de
Cancer Medicine. , 2023

Link: https://hdl.handle.net/1..

13

Clinical outcomes after CPX-351 in patients with high-risk ..:

Bernal, Teresa ; Fernández Moreno, Ainhoa ; De Laiglesia, Almudena...
Cancer Medicine;12(14). , 2023

Link: https://hdl.handle.net/1..

14

Incidence, risk factors, and outcomes of second neoplasms i..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10799093/. , 2023

Link: http://www.ncbi.nlm.nih...

15

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLA..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429255/. , 2023

Link: http://www.ncbi.nlm.nih...